Clinical Trial

Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD

Study acronym: DeepUSFF
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 25, 2025 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This multicenter prospective study aims to evaluate the correlation between quantitative ultrasound fat fraction (USFF) and MRI-PDFF (Proton Density Fat Fraction) for liver fat quantification in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). The study will compare the diagnostic accuracy of quantitative ultrasound imaging against MRI-PDFF as the reference standard.
Trial Details
NCT Number NCT07192159
Lead Sponsor Seoul National University Hospital
Collaborators: Northeastern Ohio Radiology Research and Education Fund
Conditions Metabolic Dysfunction-Associated Steatotic Liver Disease, Hepatic Steatosis, Liver Disease Parenchymal
Enrollment 62 participants
Start Date 2025-06-24
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-25